• Computational Hapten Design for Dual Toxin Detection

  2026-09-27

  This study combines computational hapten screening with monoclonal-antibody development to improve recognition of both amatoxins and phallotoxins, then integrates the antibodies into a dual-target fluorescent immunochromatographic assay. The reported sensitivity and mushroom-sample results support its potential as a rapid screening approach, while further validation is needed before assuming equivalent performance across diverse samples and settings.

• From Cell Counts to Mechanism: CCK-8 in Translation

  2026-09-26

  A translational perspective on using CCK-8 to evaluate cell responses in peritoneal membrane injury research—what WST-8 signals reveal, where they can mislead, and how to pair viability measurements with mechanistic assays.

• Atorvastatin Workflows for Ferroptosis Research

  2026-09-25

  Atorvastatin is a practical HMG-CoA reductase inhibitor for connecting cholesterol-pathway perturbation with vascular phenotypes and emerging ferroptosis questions. This guide translates the HCC study into a cautious, reproducible workflow, with dose-setting, controls, and troubleshooting steps for cell-based research.

• SpCas9 mRNA: Design, Mechanism & Workflow

  2026-09-25

  SpCas9 mRNA (ARCA, 5mCTP, ψUTP) provides an RNA-based source of Streptococcus pyogenes Cas9 for guide-directed CRISPR-Cas9 genome editing. Its cap, poly(A) tail, modified nucleotides, and encoded nuclear localization signals are product-design features; actual editing depends on guide choice, delivery, and cellular DNA repair.

• HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody

  2026-09-24

  Use this Alexa Fluor 488 secondary to visualize human IgG binding in fluorescence-based assays, from antigen-binding ELISA to imaging and flow cytometry. The workflow guide also explains an important boundary for vaccine research: an anti-human reagent cannot be assumed to detect antibodies from the rodent models used in preclinical studies.

• Erastin: A Ferroptosis Inducer for Cancer Research

  2026-09-24

  Erastin is a ferroptosis inducer used to investigate iron-dependent oxidative cell death, particularly in cancer models with RAS or BRAF mutations. This guide distinguishes its established system Xc⁻ and glutathione-related effects from earlier VDAC findings, and summarizes product specifications and practical assay considerations.

• CAPE Protects Against C. difficile by Inhibiting TcdB

  2026-09-23

  Guo and colleagues report that caffeic acid phenethyl ester (CAPE) inhibits the Clostridioides difficile toxin TcdB and improves disease-associated outcomes in a mouse infection model. The study also links CAPE treatment to shifts in gut microbiota and metabolites, while leaving questions about the strength of direct-binding evidence and the extent to which microbiota changes cause protection.

• Naloxone Hydrochloride: Research Workflows

  2026-09-23

  Build more interpretable opioid receptor, neural stem cell, immune, and behavioral assays with a controlled naloxone hydrochloride workflow. The guide combines receptor pharmacology with receptor-independent controls, solvent discipline, and a reference-study framework for validating phenotype before mechanism.

• Biotin-tyramide (A8011): Practical TSA Guide

  2026-09-22

  Biotin-tyramide is a biotin phenol-type reagent for HRP-driven tyramide signal amplification in fixed-cell and tissue immunohistochemistry (IHC) and in situ hybridization (ISH). It should be prepared in DMSO or ethanol rather than water, used promptly after dissolution, and not treated as a diagnostic reagent or a long-term aqueous stock.

• Laminin (925-933) for Cell Migration Assays

  2026-09-22

  Laminin (925-933) is a defined Laminin B1 chain peptide for separating receptor-driven attachment from chemotaxis in reproducible cell assays. Its compact sequence supports controlled concentration-response, competition, and matrix-comparison experiments without the compositional variability of whole basement membrane extracts.

• Atorvastatin and Ferroptosis in Hepatocellular Carcinoma

  2026-09-21

  Wang and colleagues developed a four-gene ferroptosis-related prognostic signature for hepatocellular carcinoma and used Connectivity Map screening to identify Atorvastatin as a candidate therapeutic compound. In vitro and in vivo experiments linked Atorvastatin exposure with ferroptosis-associated antitumor activity, while also defining important limitations for translating this computationally guided finding into oncology research.

• Verbascoside for Neuroimmune Pathway Studies

  2026-09-21

  Verbascoside is a PKC/NF-κB inhibitor with a useful assay history in osteoclastogenesis. This article develops a translational framework for testing whether its pathway activity can inform TMJ inflammation, microglial pruning, and neuroimmune assay design without overstating unproven effects.

• NUAK1-Mediated Tau Ser356 in Alzheimer’s Disease

  2026-09-20

  Taylor and colleagues identify p-tau Ser356 as a pathology-associated tau species that increases with Alzheimer’s disease progression and localizes to neurofibrillary tangles and synapses. Their slice-culture experiments show that NUAK inhibition has markedly different effects in mouse and human tissue, supporting careful model selection when evaluating tau-directed interventions.

• Atorvastatin Workflows for Ferroptosis Research

  2026-09-19

  Atorvastatin is more than a cholesterol biosynthesis inhibitor: it is a practical probe for connecting HMG-CoA reductase activity with ferroptosis, vascular signaling, and tumor-cell behavior. This workflow-oriented guide covers formulation, dose finding, orthogonal readouts, translational boundaries, and troubleshooting for reproducible studies.

• Homer1a–Caspase-6 Signaling in Inflammatory Pain

  2026-09-18

  A 2025 preclinical study identifies Homer1a as an upstream suppressor of caspase-6/TNF-α signaling in the spinal dorsal horn during carrageenan-induced inflammatory pain. Pharmacological inhibition and lentiviral overexpression experiments connect this pathway to microglial activation and thermal hypersensitivity, providing a mechanistic framework for studying non-apoptotic caspase-6 activity in pain biology.

8554 records 1/571 page Next 12345 下5页 Last page